E-state modeling of HIV-1 protease inhibitor binding independent of 3D information

Journal of Chemical Information and Computer Sciences

Volumn 42, Issue 2, 2002, Pages 290-298

  Maw, Hlaing Hlaing ^a,b   Hall, Lowell H ^a  

^a EASTERN NAZARENE COLLEGE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERACTION ENERGIES;

COMPUTER SIMULATION; ERROR ANALYSIS; HYDROGEN BONDS; STATISTICAL METHODS; TOPOLOGY;

ENZYME INHIBITION;

PROTEINASE INHIBITOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HYDROGEN BOND; METABOLISM; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

HIV PROTEASE INHIBITORS; HYDROGEN BONDING; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036489450     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci010091z     Document Type: Article

References (34)

1. Greer, J.; Erickson, J.W.; Baldwin, J.J.; Varney, M.D. Application of the Three-Dimensional Structures of Protein Target Molecules in Structure-Based Design. J. Med. Chem. 1994, 37, 1035-1054.
2. Bugg, C.E.; Carson, W.M.; Montgomery, J.A. Drugs by Design. Sci. Am. 1993, Dec., 92-98.
3. Kier, L.B.; Hall, L.H. Molecular Structure Description: The Electrotopological State; Academic Press: San Diego, CA, 1999.
4. Kier, L.B.; Hall, L.H. Inhibition of Salicylamide Binding: An Electrotopological State Analysis. Med. Chem. Res. 1992, 2, 497-502.
5. Gough, J.D.; Hall, L.H. QSAR Models of the Antileukemic Potency of Carboquinones: Electrotopological State and Chi Indices. J. Chem. Inf. Comput. Sci. 1999, 39, 356-361.
6. (a) Huuskonen, J. Estimation of Aqueous Solubility for a Diverse Set of Organic Compounds Based on Molecular Topology. J. Chem. Inf. Comput. Sci. 2000, 40, 773-777.
7. (b) Huuskonen, J. QSAR Modeling with the Electrotopological State: TIBO Derivatives. J. Chem. Inf. Comput. Sci. 2001, 41, 425-429.
8. 50 Values for ACAT Inhibitors from Molecular Structure. J. Chem. Inf. Comput. Sci. 2000, 40, 706-723.
9. Gozolbes, R.; Galvez, J.; Garcia-Domenech, R.; Derouin, F. Molecular Search of New Active Drugs Against Toxoplasma Gondii. SAR QSAR Environ. Res. 1999, 10, 47-60.
10. Tantillo, C.; Ding, J.; Jacobo-Molina, A.; Nanni, R.G.; Boyer, P.L.; Hughes, S.H.; Pauwels, R.; Andires, K.; Jansen, P.A.; Arnold, E. Locations of Anti_AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J. Mol. Biol. 1994, 243, 369-387.
11. Karn, J.; Graeble, M. New Insights into the Mechanism of Hiv-1 Tran-Activation. Trends Genet. 1992, 8, 365-368.
12. Antoni, B.; Stein, S.B.; Rabson, A.B. Regulation of human immunodeficiency virus infection: Implications for pathogenesis. Adv. Virus Res. 1994, 43, 53-145.
13. Huff, J.R. HIV Protease: A Novel Chemotherapeutic Target for AIDS. J. Med. Chem. 1991, 34, 2305-2314.
14. Kohl, N.E.; Emini, E.A.; Schleif, W.A.; Davis, L.K.J.; Heimbach, J.C.; Dixon, R.A.; Scolnick, E.M.; Sigal, I. Active human immunodeficiency virus is required for viral infection. Proc. Nat. Acad. Sci. U.S.A. 1998, 85, 4686.
15. Farmergie, W.G.; Loeb, D.D.; Casavant, N.C.; Hutchinson, C.A., III; Edgel, M.H.; Swanstrom, R. Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli. Science 1987, 236, 305-308.
16. Holloway, M.K.; Wai, J.M.; Halgren, T.A.; Fitzgerald, P.M.D.; Vacca, J.P.; Dorsey, B.D.; Levin, R.B.; Thompsom, W.J.; Chen, J.; deSolms, S.J.; Gaffin, N.; Ghosh, A.K.; Giuliani, E.A.; Graham, S.L.; Guare, J.P.; Hungate, R.W.; Lyle, T.A.; Sanders, w.M.; Tucker, T.J.; Wiggins, M.; Wiscount, C.M.; Woltersdorf, O.W.; Young, S.D.; Darke, P.L.; Zugay, J.A. Priori Prediction of Activity for HIV-1 Protease Inhibitors Employing Energy Minimization in the Active Site. J. Med. Chem. 1995, 38, 305-317.
17. Hall, L.H.; Mohney, B.K.; Kier, L.B. Comparison of electrotopological state indexes with molecular orbital parameters: Inhibition of MAO by hydrazides. Quant. Struct.-Act. Relat. 1993, 12, 44-48.
18. Hall, L.H.; Kier, L.B. Electrotopological State Indices for Atom Types: A Novel Combination Of Electronic, Topological and Valence State Information. J. Chem. Inf. Comput. Sci. 1995, 35, 1039-1045.
19. Gough, J.D.; Hall, L.H. QSAR Models of the Antileukemic Potency of Carhoquinones: Electrotopological State and χ Indices. J. Chem. Inf. Comput. Sci. 1999, 39, 356-361.
20. Gough, J.D.; Hall, L.H. Modeling the toxicity of amide herbicides using the electrotopological state. Environ. Toxicol. Chem. 1999, 18, 1069-1075.
21. Kier, L.B.; Hall, L.H. Database Organization and Similarity Searching with E-State Indices. In Symposium on Computer Methods for Structure Representation; Kluwer Academic Publishing Co.: New York, Dordrecht, The Netherlands, 2001; pp 33-49.
22. Hall, L.H.; Kier, L.B. The Electrotopological State: Structure Modeling for QSAR and Database Analysis. In Topological Indices and Related Descriptors in QSAR and QSPR; Devillers, J., Balaban, A.T., Eds.; Gordon and Breach: Reading, U.K., 1999; pp 491-562.
23. Kier, L.B.; Hall, L.H. Molecular Connectivity in Structure-Activity Analysis; Research Studies Press, John Wiley and Sons: Chichester, U.K., 1986.
24. Hall, L.H.; Kier, L.B. The Molecular Connectivity Chi Indexes and Kappa Shape Indexes in Structure-Property Relations. In Reviews of Computational Chemistry; Boyd, D., Lipkowitz, K., Eds.; VCH Publishers: Weinheim, Germany, 1991; Chapter 9, pp 367-422.
25. Hall, L.H.; Kier, L.B. Molecular Connectivity Chi Indices for Database Analysis and Structure-Property Modeling. In Topological Indices and Related Descriptors in QSAR and QSPR; Devillers, J., Balaban, A.T., Eds.; Gordon and Breach: Reading, U.K., 1999; pp 307-360.
26. Kier, L.B.; Hall, L.H. The Kappa Indices for Modeling Molecular Shape and Flexibility. In Topological Indices and Related Descriptors in QSAR and QSPR; Devillers, J., Balaban, A.T., Eds.; Gordon and Breach: Reading, U.K., 1999; pp 455-490.
27. Maw, H.H.; Hall, L.H. E-State Modeling of Dopamine Transporter Binding. Validation of Model for a Small Data Set. J. Chem. Inf. Comput. Sci. 2000, 40, 1270-1275.
28. Maw, H.H.; Hall, L.H. E-State Modeling of Corticosteroid Binding Affinity. Validation of Model for a Small Data Set. J. Chem. Inf. Comput. Sci. 2001, 41, 1248-1254.
29. Hall, L.H.; Kier, L.B. The E-State as the Basis for Molecular Structure Space Definition and Structure Similarity. J. Chem. Inf. Comput. Sci. 2000, 40, 784-791.
30. ChemDraw, ver 4.5; CambridgeSoft: Cambridge, MA 02139.
31. Molconn-Z, ver 3.50, available from Hall Associates Consulting, 2 Davis Street, Quincy, MA, 02170; also from EduSoft, LC, PO Box 1811, Ashland, VA 23005, and SciVision, Inc, 200 Wheeler Road, Burlington, MA 01803.
32. SAS, ver 8.0, SAS Institute, Cary, NC 27513.
33. Thompson, W.J.; Fitzgerals, P.M.D.; Holloway, M.K.; Emini, E.; Darke, P.L.; McKeever, B.M.; Schleif, W.A.; Quintero, J.C.; Zugay, J.A.; Tucker, T.J.; Schwering, J.E.; Homnick, C.F.; Nunberg, J.; Springer, J.P.; Huff, J.R. Synthesis and Antiviral Activity of a Series of HIV-1 Protease Inhibitors with Functionality Tethered to the P1 or P1′ Phenyl Substituents: X-ray Crystal Structure Assisted Design. J. Med. Chem. 1992, 35, 1685-1701.
34. Kier, L.B.; Hall, L.H. Intermolecular Accessibility: The Meaning of Molecular Connectivity. J. Chem. Inf. Comput. Sci. 2000, 40, 792-795.